drugset / Trial / NCT02489786

A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital

NCT02489786

Phase 4 Completed 71 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

Digoxin is the primary cardiac glycoside in clinical use. Because of the narrow therapeutic index and risk of toxicity, therapeutic drug monitoring is highly recommended. In Egypt, most cardiologists give digoxin holiday for both atrial fibrillation and heart failure, it is not clear if the interrupted digoxin regimens are effective since serum digoxin concentrations might fall below the therapeutic range. Objective: To evaluate and compare the digoxin serum concentration and patient's quality of life in the continuous versus interrupted digoxin dosing regimens.

Timeline

Start
2012-10
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Digoxin Other / unclassified 0.125 mg
Comparator Digoxin Other / unclassified 0.25 mg

Indications